Statistics for CorMedix (id:6706 CRMD)

Valuation metrics

Market cap

626.80M

Enterprise value

606.20M

Trailing P/E (ttm)

-10.96

Forward P/E

21.52

PEG ratio

21.52

Price/Sales (ttm)

51.12

Price/Book (mrq)

10.19

Enterprise Value/Revenue

49.44

Enterprise Value/EBITDA

-11.94

Overview

Shares outstanding

60.68M

Float

60.11M

Shares short

6.28M

% Held by insiders

0.01%

% Held by institutions

0.32%

Average volume (10 days)

1.15M

Average volume (90 days)

Price summary

52-Week low

2.89

52-Week high

13.85

52-Week change

63.32%

Beta

1.58

50-Day moving average

9.80

200-Day moving average

5.94

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

March 26th, 2019

Ex-dividend date

Last split factor

2:1

Last split date

March 26th, 2019

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

0.00%

Operating margin

-28.70%

Operational effectiveness

Return on assets

-37.69%

Return on equity

-65.04%

Income statement

Revenue (ttm)

0.21

Revenue per share (ttm)

0.21

Quarterly revenue growth (yoy)

Gross profit (ttm)

0.00

EBITDA

-50,766,364.00

Net income to common (ttm)

-46,148,452.00

Diluted EPS (ttm)

-0.80

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

46.03M

Total cash per share (mrq)

0.76

Total debt (mrq)

556.42K

Total Debt/Equity (mrq)

0.95

Current ratio (mrq)

395.80%

Book value per share (mrq)

1.01

Cash flow

Cash flow statement

-55,745,812.00

Levered free cash flow (LFCF)

-39,781,652.00